Literature DB >> 2785227

Increased production of interleukin-2 and IL-2 receptor in primary IgA nephropathy.

F P Schena1, G Mastrolitti, E Jirillo, I Munno, N Pellegrino, A R Fracasso, L Aventaggiato.   

Abstract

The production of interleukin-2 (IL-2) by peripheral blood mononuclear cells (PBMC) in 13 patients with IgA nephropathy (IgAN) and 9 patients with chronic glomerulonephritis was investigated. Moreover, the distribution of IL-2 receptor (IL-2R) expression was studied in the purified T cell population versus the non-T cell population of IgAN patients. The results show a spontaneous significant production of IL-2 in cultures of PBMC from patients with IgAN (P less than 0.025) that increased after PHA stimulation. IgAN patients also had a significantly higher expression of IL-2R on the surface of PBMC than did patients with chronic glomerulonephritis (P less than 0.05). IL-2R was usually detected on unstimulated purified T cells that expressed the activation DR antigen. Moreover, a high number of DR helper T cells was associated to a reduced number of suppressor T cells (OKT8+M1+). These findings suggest that the increased production of IL-2 in patients with IgAN may be responsible for the increased activity of helper T cells. The high number of IL-2R expressed by freshly separated PBMC implies an in vivo continuous stimulation of these cells, and this finding is in agreement with the demonstrated spontaneous hyperproduction of IL-2. Moreover, the low number of suppressor T cells may contribute to the overactivity of helper T cells bearing IL-2R in IgAN patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785227     DOI: 10.1038/ki.1989.67

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

1.  Secretory IgA are elevated in both saliva and serum of patients with various types of primary glomerulonephritis.

Authors:  G Rostoker; H Terzidis; M Petit-Phar; D Meillet; P Lang; J M Dubert; G Lagrue; B Weil
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

2.  Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy.

Authors:  F P Schena; A Pastore; N Ludovico; R A Sinico; S Benuzzi; V Montinaro
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

3.  Increased IL-10 production by stimulated whole blood cultures in primary IgA nephropathy.

Authors:  J W De Fijter; M R Daha; W E Schroeijers; L A van Es; C Van Kooten
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

Review 4.  Immunopathogenesis of experimental IgA nephropathy.

Authors:  A Rifai
Journal:  Springer Semin Immunopathol       Date:  1994

Review 5.  T cell subsets in glomerular diseases.

Authors:  S Florquin; M Goldman
Journal:  Springer Semin Immunopathol       Date:  1994

6.  T-lymphocyte activation in IgA nephropathy: serum-soluble interleukin 2 receptor level, interleukin 2 production, and interleukin 2 receptor expression by cultured lymphocytes.

Authors:  K N Lai; J C Leung; F M Lai; J S Tam
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

7.  Profiles of immunoregulatory cytokine production in vitro in patients with IgA nephropathy and their kindred.

Authors:  V Scivittaro; L Gesualdo; E Ranieri; C Marfella; S A Schewn; S N Emancipator; F P Schena
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

8.  Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy.

Authors:  F P Schena; V Scivittaro; E Ranieri; R Sinico; S Benuzzi; M Di Cillo; L Aventaggiato
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

Review 9.  The progression of renal diseases: on the pathogenesis of renal interstitial fibrosis.

Authors:  G A Müller; J Markovic-Lipkovski; H P Rodemann
Journal:  Klin Wochenschr       Date:  1991-09-03

10.  Cytokine production by peripheral blood mononuclear cells in IgA nephropathy.

Authors:  K N Lai; J C Leung; P K Li; S F Lui
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.